Assessing the immunogenic and protective potential of different viral vector regimes, in the mouse model of tuberculosis infection

Registos relacionados

• Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection
  Por: Betts, G, et al.
  Publicado em: (2012)
• Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice
  Por: Griffiths, K, et al.
  Publicado em: (2013)
• Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection.
  Por: Gareth Betts, et al.
  Publicado em: (2012-01-01)
• Th1/Th17 cell induction following vaccination with the novel tuberculosis vaccine MVA85A and their role in Mycobacterium tuberculosis challenge
  Por: Griffiths, K, et al.
  Publicado em: (2011)
• Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A
  Por: Stylianou, E, et al.
  Publicado em: (2015)